Can a Sick Company Face Recovery Suits? Supreme Court Clarifies Section 22(1) Application

Introduction

The Supreme Court of India recently addressed critical issues surrounding the applicability of Section 22(1) of the Sick Industrial Companies (Special Provisions) Act, 1985, in the case of Fertilizer Corporation of India Limited & Ors. vs M/s Coromandal Sacks Private Limited. This judgment clarifies the legal landscape for recovery suits against companies declared sick under the Act, particularly focusing on the suspension of legal proceedings and the implications for creditors.

Case Background

The case arose from appeals against a common judgment by the High Court of Telangana, which partly allowed appeals from both the original plaintiff, M/s Coromandal Sacks Private Limited, and the original defendants, Fertilizer Corporation of India Limited (FCIL) and others. The original plaintiff sought recovery of amounts due for the supply of HDPE bags, while the defendants contended that the suit was not maintainable due to the provisions of the Sick Industrial Companies Act, as FCIL had been declared a sick company.

The trial court had decreed the suit in favor of the plaintiff, awarding amounts for price differences, penalties, and interest. However, the defendants argued that the suit was barred under Section 22(1) of the Act, which suspends legal proceedings against sick companies.

What The Lower Authorities Held

The trial court found in favor of the plaintiff on several counts, including the acknowledgment of the supply of bags and the unjustified deductions made by the defendants. However, it also recognized the defendants' right to deduct amounts for liquidated damages. The court awarded interest at 12% per annum on the amounts due.

On appeal, the High Court modified the trial court's decree, allowing the defendants to deduct liquidated damages but granting the plaintiff 24% compound interest on the amounts due, citing the provisions of the Interest on Delayed Payments to Small Scale and Ancillary Industrial Undertakings Act, 1993.

The Court's Reasoning

The Supreme Court's analysis focused on two primary issues: the applicability of Section 22(1) of the Sick Industrial Companies Act and the legality of the interest rate awarded by the High Court. The Court emphasized that for the suspension of legal proceedings to apply, three conditions must be met:

1. An inquiry under Section 16 of the Act must be pending, or a scheme under Section 17 must be under consideration.

2. The proceedings must fall within the categories specified in Section 22(1).

3. The proceedings must threaten the assets of the sick company or interfere with the formulation of the rehabilitation scheme.

In this case, the Court found that while the first two conditions were satisfied, the third was not. The suit for recovery was deemed not to threaten the assets of the sick company, as it was merely for the determination of liability and did not involve execution or distress proceedings.

Statutory Interpretation

The Court interpreted Section 22(1) as providing a protective shield for sick companies, ensuring that legal proceedings do not impede the rehabilitation process. The provision was designed to allow companies to focus on recovery without the burden of ongoing litigation. The Court also highlighted the need for a harmonious interpretation of the Sick Industrial Companies Act and the Interest on Delayed Payments Act, recognizing the importance of both in the context of industrial recovery and creditor rights.

Why This Judgment Matters

This ruling is significant for legal practice as it clarifies the boundaries of creditor rights against sick companies. It reinforces the principle that while creditors have rights to recover debts, these rights are subject to the provisions of the Sick Industrial Companies Act, which aims to facilitate the revival of sick companies. The judgment underscores the importance of acknowledging debts before the BIFR to proceed with recovery actions and sets a precedent for future cases involving sick companies.

Final Outcome

The Supreme Court upheld the High Court's decision to award 24% interest but modified the period for which interest would be applicable, excluding the time during which FCIL was declared a sick company. The appeals were disposed of accordingly, emphasizing the need for a balanced approach to creditor rights and the rehabilitation of sick companies.

Case Details

• Case Title: Fertilizer Corporation of India Limited & Ors. vs M/s Coromandal Sacks Private Limited
• Citation: 2024 INSC 348
• Court: IN THE SUPREME COURT OF INDIA
• Bench: Justice J.B. Pardiwala, Justice Sandeep Mehta
• Date of Judgment: 2024-04-26